MAIOFB VASCULAR - Journal of the American College of …, 2011 - Am Coll Cardio Found ... Radu, Takayuki Okamura, Hector M. Garcia-Garcia, COHERENCE TOMOGRAPHY DEVICES: ASSESSMENT WITH 3-DIMENSIONAL OPTICAL IMPLANTATION OF BIORESORBABLE VASCULAR SCAFFOLDING FATE OF SIDE BRANCHES AT 6 AND 12 MONTHS AFTER ... All 2 versions
[PDF] from arxiv.orgWJ Borucki, DG Koch, G Basri… - The Astrophysical …, 2011 - iopscience.iop.org WILLIAM J. BORUCkI1, DAVID G. KOCH1, GIBOR BASRI2, NATALIE BATALHA3, TIMOTHY M. BROwN4, STEPHEN T. BRYSON1, DOUGLAS CALDwELL5, JøRGEN CHRISTENSEN-DALSGAARD6, WILLIAM D. COCHRAN7, EDNA DEVORE5, EDwARD ... Cited by 46 - Related articles - All 10 versions
PJ Maguire, E Gardner, AB Jack, P Zei… - … ™) for Treatment of …, 2011 - peeremed.com Abstract: Abstract Objectives: This porcine pre-clinical investigation sought to demonstrate a new and novel application for radiosurgery, the ablation of cardiac arrhythmias. Pre-clinical studies in the porcine animal model were used to investigate the accuracy with which the ... Cached
[PDF] from centromedicoathenas.com.brMDL O'Connell, SA Roberts… - Journal of Clinical …, 2011 - Endocrine Soc Design and Setting: Single center, randomized, double-blind, placebo-controlled trial to investigate the effects of 6 months T (25–75 mg daily) on muscle strength, body composition, physical function, and quality of life (QoL). Participants were assessed at the end of treatment (6 ... Cited by 3 - Related articles - All 4 versions
[CITATION] Twelve versus 36 months of adjuvant imatinib (IM) as treatment of operable GIST with a high risk of recurrence: final results of a randomized trial (SSGXVIII …
H Joensuu, M Eriksson, J Hartmann - Program and abstracts of the American …, 2011 Cited by 5 - Related articles